NATCO Pharma Limited (NSE:NATCOPHARM)

NATCO Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	26,902	1,200	704	1,319	1,111	258
Short-Term Investments	5,141	23,699	13,208	6,612	6,488	7,919
Cash & Short-Term Investments	32,043	24,899	13,912	7,931	7,599	8,177
Cash Growth	30.08%	78.97%	75.41%	4.37%	-7.07%	-9.40%
Accounts Receivable	17,189	12,466	11,889	8,561	6,206	4,129
Other Receivables	-	1,045	706	351	545	721
Receivables	17,291	13,605	12,685	9,014	6,855	4,981
Inventory	8,180	8,494	7,917	8,089	8,620	9,104
Prepaid Expenses	-	305	289	283	326	226
Other Current Assets	12,153	5,397	5,432	4,686	1,467	960
Total Current Assets	69,667	52,700	40,235	30,003	24,867	23,448
Property, Plant & Equipment	26,923	26,573	24,350	23,034	23,084	22,372
Long-Term Investments	2,596	1,528	959	873	1,044	1,519
Goodwill	597	574	560	552	507	-
Other Intangible Assets	2,005	2,087	1,371	1,326	822	94
Long-Term Deferred Tax Assets	1,176	501	194	-	-	-
Other Long-Term Assets	1,337	2,345	1,394	786	767	472
Total Assets	104,301	86,308	69,063	56,574	51,091	47,919
Accounts Payable	5,126	2,749	2,355	2,638	1,618	1,462
Accrued Expenses	-	977	843	691	569	480
Short-Term Debt	2,528	2,731	3,781	1,744	4,205	2,821
Current Portion of Leases	32	17	27	6	35	9
Current Income Taxes Payable	1,373	790	323	101	9	13
Other Current Liabilities	7,941	2,171	2,399	1,651	668	471
Total Current Liabilities	17,000	9,435	9,728	6,831	7,104	5,256
Long-Term Leases	47	46	53	11	80	9
Pension & Post-Retirement Benefits	-	181	266	468	574	610
Long-Term Deferred Tax Liabilities	32	2	2	124	301	413
Other Long-Term Liabilities	680	521	483	402	396	397
Total Liabilities	17,759	10,185	10,532	7,836	8,455	6,685
Common Stock	358	358	358	365	365	365
Additional Paid-In Capital	-	12,019	12,019	14,065	14,078	13,915
Retained Earnings	-	63,061	45,252	33,518	27,261	26,277
Comprehensive Income & Other	86,140	632	902	790	932	659
Total Common Equity	86,498	76,070	58,531	48,738	42,636	41,216
Minority Interest	44	53	-	-	-	18
Shareholders' Equity	86,542	76,123	58,531	48,738	42,636	41,234
Total Liabilities & Equity	104,301	86,308	69,063	56,574	51,091	47,919
Total Debt	2,607	2,794	3,861	1,761	4,320	2,839
Net Cash (Debt)	29,436	22,105	10,051	6,170	3,279	5,338
Net Cash Growth	30.54%	119.93%	62.90%	88.17%	-38.57%	-6.86%
Net Cash Per Share	164.34	123.42	56.00	33.80	17.98	29.25
Filing Date Shares Outstanding	179.13	179.11	179.11	182.47	182.52	182.34
Total Common Shares Outstanding	179.13	179.11	179.11	182.47	182.52	182.34
Working Capital	52,667	43,265	30,507	23,172	17,763	18,192
Book Value Per Share	482.88	424.71	326.79	267.10	233.60	226.04
Tangible Book Value	83,896	73,409	56,600	46,860	41,307	41,122
Tangible Book Value Per Share	468.35	409.85	316.01	256.81	226.31	225.53
Land	-	5,265	3,692	2,855	2,641	2,476
Buildings	-	11,090	11,080	10,593	9,734	8,966
Machinery	-	19,485	18,340	17,616	16,798	15,013
Construction In Progress	-	2,254	1,373	643	1,295	2,234

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.